The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Interview with Fernando Cruzado, Vice President & Industry Lead Chemicals and Holger Peterkord, Senior Principal & Capex capability lead at Efeso Group
US paints and coatingsmaker PPG has agreed to sell its silicas products business for abou $310 million to Warsaw, Poland-based Qemetica, a manufacturer of soda ash...
The Italian Association for the Study and Control of Contamination (ASCCA), in collaboration with the International Confederation of Contamination Control Societies...
BASF's Coatings division has inaugurated its new application and technical center in Jiangmen, China, which is located within the site of BASF Coatings (Guangdong) (BCG).
Barentz recently appointed Lars Schneider as the new Chief Executive Officer for the EMEA region, starting October 1st, 2024. Lars will also become a member of the...
Aurigene Pharmaceutical Services, the CRDMO arm of India-based Dr. Reddy’s, has signed a non-binding Memorandum of Understanding (MoU) with Kainomyx, a US-based company...
